Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Mass Casualty IncidentDehydration
Interventions
OTHER

hypodermoclysis via recombinant hyaluronidase-facilitated subcutaneous infusion

Above

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00386386 - Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial | Biotech Hunter | Biotech Hunter